Zogenix, Inc. and Desitin Pharmaceuticals GmbH announced that the Danish Medicines Agency of Denmark has approved the Marketing Authorization Application for SUMAVEL DosePro Needle-Free Delivery System.
Integrated DNA Technologies, a leader in oligonucleotide synthesis, and Rensselaer Polytechnic Institute announced the launch of the UNAFold secondary structure prediction software at IDT.
A robust, off-the-shelf solution for screening Human Retinoic Acid Receptor Gamma (RAR?) is now available from INDIGO Biosciences. INDIGO Nuclear Receptor Assay Kits go from freezer to data in 24 hours with minimal hands-on time.
Thermo Fisher Scientific Inc. offers a ‘guide to good washing practice,’ an online guide is designed as a step-by-step tool, providing detailed guidance on obtaining secure and reliable performance with every use of the its Wellwash microplate washers.
CYTOO Cell Architects introduced CYTOOplates 96 for pharma, biotech and academic screening center customers employing high content cell-based assays for research, drug safety, and drug screening applications.
Aushon BioSystems, Inc. has partnered with LightArray Biotech Company, Ltd., to provide Aushon’s suite of multiplex biomarker products and services to pharmaceutical, biotechnical, and academic research institutions located in mainland China.
Advanced Clinical, a leader in pharmaceutical development, announced an addition to its leadership team: Mark Lanfear has been hired as Vice President, Clinical Operations to lead Advanced Clinical in its expansion of service offerings for 2011.
Optimer Pharmaceuticals, Inc. announced that it has completed the submission of its new drug application to the U.S. Food and Drug Administration for fidaxomicin to treat patients with Clostridium difficile infection and to prevent recurrences of CDI.
Shire plc announced topline results from FAST-3 (For Angioedema Subcutaneous Treatment), the largest of the Phase 3 trials studying the use of Firazyr for treatment of acute attacks of hereditary angioedema.
New research shows the NSAID Celebrex may help prevent some non-melanoma skin cancers from developing in patients who have pre-cancerous actinic keratoses lesions and are at high risk for having the disease.
A scientific report has found evidence of reduced activity of an energy-generating enzyme in deceased young adult brain donors who carry a common genetic risk factor for Alzheimer's disease.
Mayo Clinic researchers have shown why, in a minority of HIV patients, immune function improves despite a lack of response to standard anti-retroviral treatment. In these cases, researchers say, the virus has lost its ability to kill immune cells.
New research shows that anti-microbial medications are a common cause of drug-induced liver injury leading to acute liver failure, with women and minorities disproportionately affected.
The U.S. Food and Drug Administration has approved Octapharma USA’s investigational new drug application for octaplex as a fast track product for reversing anticoagulation therapy in patients needing urgent Surgery or invasive procedures.
BioClinica, Inc., a global provider of clinical trial management services, announced a strategic partnership with Kaizen Clinical Services, Inc., an oncology-focused contract research organization.